A real life use of ruxolitinib in patients with acute and chronic graft versus host disease refractory to corticosteroid treatment in Latin American patients

INTRODUCTION: Graft-versus-host disease (GVHD) is a serious complication in allogeneic transplantation. The first-line treatment is high doses of corticosteroids. In the absence of response to corticosteroids, several immunosuppressive drugs can be used, but they entail an elevated risk of severe in...

Descripción completa

Detalles Bibliográficos
Autores principales: Sarmiento, Mauricio, Jara, Veronica, Soto, Katherine, Uribe, Pablo, Ocqueteau, Mauricio, Bertin, Pablo, Pereira, Jaime
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Hematologia e Hemoterapia 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8446249/
https://www.ncbi.nlm.nih.gov/pubmed/33023864
http://dx.doi.org/10.1016/j.htct.2020.06.015

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8446249/
https://www.ncbi.nlm.nih.gov/pubmed/33023864
http://dx.doi.org/10.1016/j.htct.2020.06.015

Ejemplares similares